6th International Conference on Glycobiology, Lipids and Metabolic Disorders

Jul 29-30, 2019


Chicago, United States of America

LexisConferences Conferences feels great pleasure to invite you all to attend 6th International Conference on Glycobiology, Lipids & Metabolic Disorders (Glycobiology Conference 2019) is going to be held in Chicago, USA on July 29-30, 2019. The conference is going to bring together glycobiologists, scientists, molecular biologists, biochemists, industrial experts, delegates, sponsors and related exhibitors from all around the world to the marvelous city of Chicago, USA. The conference theme focuses on Facts, fictions, and future of Glycos & Lipids: A closure look.

Conference Highlights:

•    Glycobiology and Glycochemistry

•    Molecular Glycoscience and Monosaccharides

•    Proteoglycan and Sialic acid

•    Glycoproteomics Analysis and Mass Spectrometry

•    Protein engineering and Glycoimmunology

•    Glycolipids and Glycopeptides

•    N-linked and O-linked Glycosylation

•    Glycoconjugates, Glycomics and Metabolomics

•    Glycans and Lipids in Cancer, Neuroscience and Vaccine development

•    Lipid and Lipoprotein Metabolism

•    Protein-Lipid & Lipid-Lipid Interactions

•    Lipids in Molecular Medicine and Virology

•    Lipids in Signaling and Intracellular Trafficking

•    Structural Diversity of Lipids and its Role in Membranes

•    Carbohydrate Metabolism Disorders

•    Obesity and Nutrition

•    Diabetes, Blood Sugar & Glucose Monitoring

•    Metabolic Testing and Lipid Profiling

•    Cholesterol & Lipid Metabolism Disorders

•    Role of Cholesterol in Hypertension and Stroke

•    Role of sugars in Galactosemia & Phenylketonuria

•    Chronic Myocardial Ischemia, Hypoglycemia & Hyperglycemia

Various members from all around the globe have focused their research and expertise on learning more and more about various biomolecules and use of Glycobiology, Lipids and related Metabolic disorders, so this is a best chance to meet the global participants in the wider arena of Biochemistry to share information, meeting with current and expert researchers and receive name recognition in this two day premier event.

LexisConferences Conferences Ltd invites all the participants across the globe to attend the 6th International Conference on Glycobiology Lipids & Metabolic Disorders during July 29- July 30, 2019, at ChicagoUSA.

Glycobiology Conference 2019 is designed to meet all renowned and eminent speakers, research experts from all around the globe with delegates, exhibitors, and industry experts and workshop symposiums.

For more details: https://www.lexisconferences.com/glycobiology

Details of Glycobiology Conference 2019 in Chicago:

Conference Name



Glycobiology Conference 2019

Chicago, USA

July 29-30, 2019


Market Analysis

Market Report:

Glycobiology Conference 2019 welcomes attendees, presenters, and exhibitors from all over the world to Chicago, USA. We are delighted to invite you all to attend and register for the “6th International Conference on Glycobiology, Lipids & Metabolic Disorders" which is going to be held during July 29-30, 2019 in Chicago, USA.

The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Glycobiology Conference 2019 where you will be sure to have a meaningful experience with scholars from around the world. All the members of the Glycobiology Conference 2019 organizing committee look forward to meeting you in Chicago, USA.

Importance & Scope:

Most aspects of glycobiology depend on successful researches. Glycobiology Conference 2019 aims to bring together leading academic scientists, researchers, and research scholars to exchange and share their experiences and research results about all aspects of Glycobiology leading way to the unraveled. It also provides the chance for researchers, practitioners, and educators to present and discuss the most recent innovations, trends, and concerns, practical challenges encountered and the solutions adopted in the fields of glycobiology.

Glycobiology Conference 2019 is an essential platform for presenting research about marketing, exchanging ideas about it and thus, contributes to the dissemination of knowledge for the benefit of both the academic and business. Glycobiology is where the future intersects. This event brings together eminent researchers and associates to explore the emerging field. We bring together knowledge, creative, and technology leaders from the biology industry for the most current and relevant discussions.

Glycobiology Market Global Forecast to 2019: The Glycobiology market will reach $928.11 million by 2019, growing at a CAGR of 12.62% during the forecast period (2014–2019) and is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, which is a positive sign in the field of modern era research. This report describes the global Glycobiology market by application, end users, products, and geographies. According to the World Bank and agencies, funding for research and development activities in Asia was about $158.94 billion in 2001 and increased to $329.31 billion in 2010. Similarly, in the U.S.A, overall funding for research and development was about $291.77 billion in 2001, which drastically increased to $428.94 billion in 2010. A number of factors such as increasing focus of government and private funding for Glycobiology and proteomics research and huge investment by pharmaceutical and research companies are the key promoters for the growth of this market. On the basis of the product, the market is distributed into enzymes, instruments, diagnostic kits, and chemical reagents and the enzymes segment like glycosidases, neuraminidases, sialyltransferases, glycosyltransferases, and other enzymes but glycosidases is expected to the major contributor of the Glycobiology research with the largest shares in R&D activities for the development of novel drugs and therapies.

The major players in this market include Agilent Technologies (U.S.), Bruker Corp. (U.S.), Danaher Corp. (U.S.), New England Biolabs (U.S.), Prozyme Inc. (U.S.), Shimadzu Corp. (Japan), Sigma-Aldrich Corp. (U.S.), Takara Bio (Japan), Thermo Fisher Scientific (U.S.), and Waters Corp. (U.S).

Why to attend???

This conference will be focusing on all the major aspects in the fields of Glycobiology and its related research which is going across the world. It would be beneficial for all the students, research professionals whoever willing to enter into research or doing innovative research to the respective fields. As bringing the major research to the market and making it to the utility are the major focus for all the companies, this conference would be an opportunity for the people in the respective fields. Meeting with members from around the world focused on learning about biological research and growing market, this is your single best opportunity to reach the largest assemblage of participants from the scientific community. Conduct demonstrations, distribute information, meet with current and potential customers, and make a splash with a new product line, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, tactics, and the newest updates in Glycobiology growing market are hallmarks of this conference.


Myron R Szewczuk
Queen’s University, Canada

Albert M Wu
Chang-Gung University, Taiwan

Myron R Szewczuk
Queen’s University, Canada

Albert M Wu
Chang-Gung University, Taiwan

Tatiana A Korolenko
Institute of Physiology and Fundamental Medicine, Novosibirsk, Russia

Liang Lin
Northwestern University, USA

Bessi Qorri
Queen’s University, Canada

Alexandria DeCarlo
Queen’s University, Canada

Program Overview